MSH2 and neoplasm: In a group of 19 patients with both an MSI-high HNPCC-associated tumour and loss of MSH6 expression, but no detectable defect in MLH1 or MSH2, 10 pathogenic mutations in MSH6 were found in nine families (Table 1).